INNOVATORS

Leqembi Iqlik Brings Alzheimer’s Treatment Closer to Home

Pharma Outlook -
The newly available injectable option gives people with early Alzheimer’s disease a more convenient...

Three-Drug Approach Brings New Hope for HIV Treatment in Newborns

Pharma Outlook -
Early treatment in an animal study shows potential to stop the virus before it...

Post-Surgery Pain Drug Pipeline Gains Momentum as 45 Companies Advance New Treatments

Pharma Outlook -
More than 50 potential therapies are moving through clinical development as pharmaceutical companies search...

CVS Health Expands Weight Management Services with Easier Access and Personalized Care

Pharma Outlook -
The enhanced direct-to-consumer program combines virtual consultations, expert guidance, and treatment options to support...

AstraZeneca Bets $1.5 Billion on AI to Discover New Liver and Heart Treatments

Pharma Outlook -
The pharmaceutical giant partners with Insitro to use artificial intelligence and biological...

Pfizer Ends Development of Weight Loss Pill After Liver Safety Concern

Pharma Outlook -
The decision puts another hurdle in the pharmaceutical giant’s race to develop...

When AI Joins the Drug Discovery Lab

Pharma Outlook -
Novo Nordisk and Anthropic are bringing Claude into research workflows to help...

Walmart Gives Its Pharmacies a Bigger Role in Everyday Health

Pharma Outlook -
A new pilot program places trained pharmacists at the center of personalized...

Magazines

Pharmacy Management

Drug Discovery and Development

AstraZeneca Bets $1.5 Billion on AI to Discover New Liver and Heart Treatments

Pharma Outlook -
The pharmaceutical giant partners with Insitro to use artificial intelligence and biological data to identify new drug targets for complex diseases London, 15 October 2026 – AstraZeneca is...
Clinical Trial Management

Pfizer Ends Development of Weight Loss Pill After Liver Safety Concern

Pharma Outlook -
The decision puts another hurdle in the pharmaceutical giant’s race to develop an oral alternative to popular injectable obesity treatments New York, 8 October 2026 – Pfizer has...
Press release

Saudi MedTech 2026 Unites Healthcare Leaders in Riyadh to Shape the Future of Healthcare

Pharma Outlook -
Saudi MedTech 2026 brought together healthcare leaders, policymakers, clinicians, innovators, investors and technology experts in Riyadh for two days of high-level conversations, knowledge exchange and collaboration focused...
Press release

Evolution Summit 2027 to Convene Senior Clinical Development Leaders in Westlake Village, California

Pharma Outlook -
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives, taking place 19-20 January 2027 at the Four...
Load more

Clinical Trial Management

Clinical Trial Management

Pfizer Ends Development of Weight Loss Pill After Liver Safety Concern

The decision puts another hurdle in the pharmaceutical giant’s race to develop an oral alternative to popular injectable obesity treatments New York, 8 October 2026 – Pfizer has...
Clinical Trial Management

Combination Therapy Shows Promise for Better Allergy Relief

A growing body of research suggests that combining montelukast and bilastine may improve symptom control for people with allergic rhinitis while maintaining a favorable safety profile Boston, Massachusetts,...
Clinical Trial Management

Premier Health Charts a Path Through Compliance Challenges

Canadian Healthtech Company Works to Complete Financial Filings While Maintaining Focus on Digital Healthcare Innovation Montreal, Quebec, 18 June 2026 – Premier Health of America is navigating a...
Clinical Trial Management

AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy

As artificial intelligence becomes more common in clinical research, experts warn that maintaining data quality and patient safety is becoming increasingly complex Boston, Massachusetts, 21 May 2026 –...
Clinical Trial Management

J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients

Pilot study reveals promising results for planned Impella 5.5 support in complex heart surgeries. Chicago, Illinois, 7 May 2026 – Johnson & Johnson has announced encouraging results from...